Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer
- J Clin Invest. 2024 Apr 25:e176355. doi: 10.1172/JCI176355.
- 1. Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America.
- 2. Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, United States of America.
- 3. Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, United States of America.
- 4. Department of Chemical Sciences, Tata Institute of Fundamental Research, Mumbai, India.
- 5. Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, United States of America.
- 6. Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, United States of America.
- 7. Department of Medicine and Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, United States of America.
- 8. Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, United States of America.
Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identify a chromosome 3q amplicon that serves as a platform for secretory regulation in Cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase Secretory Pathway Ca2+ Transporting 1 (ATP2C1). We show that GOLIM4 recruits ATP2C1 and Golgi phosphoprotein 3 (GOLPH3) to coordinate calcium-dependent cargo loading and Golgi membrane bending and vesicle scission. GOLIM4 depletion disrupts the protein complex, resulting in a secretory blockade that inhibits the progression of 3q-amplified malignancies. In addition to its role as a scaffold, GOLIM4 maintains intracellular manganese (Mn) homeostasis by binding excess Mn in the Golgi lumen, which initiates the routing of Mn-bound GOLIM4 to lysosomes for degradation. We show that Mn treatment inhibits the progression of multiple types of 3q-amplified malignancies by degrading GOLIM4, resulting in a secretory blockade that interrupts pro-survival autocrine loops and attenuates pro-metastatic processes in the tumor microenvironment. Potentially underlying the selective activity of Mn against 3q-amplified malignancies, ATP2C1 co-amplification increases Mn influx into the Golgi lumen, resulting in a more rapid degradation of GOLIM4. These findings show that functional cooperativity between co-amplified genes underlies heightened secretion and a targetable secretory addiction in 3q-amplified malignancies.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Biochemical Assay ReagentsResearch Areas: Inflammation/Immunology
-
target: PhospholipaseResearch Areas: Others
-
target: GABA ReceptorResearch Areas: Neurological Disease
-
target: GABA ReceptorResearch Areas: Neurological Disease